Crossmark

A MOF-based nanoplatform integrating cardioprotection with chemo-photothermal therapy for safer cancer treatment

Published Online: 2026-02-03

Authors

Zhuang, Zitian

Wan, Yehong

Yan, Xueping

Zhang, Ling

Jiang, Ke
License Information

Text and Data Mining valid from 2026-02-03

Version of Record valid from 2026-02-03
More Information

Article History

Received: 11 September 2025

Accepted: 19 November 2025

First Online: 3 February 2026

Conflict of interest

: The authors declare no conflict of Interest.

Document is current